General adverse effects Even in patients with normal renal function, adverse reactions have occurred in up to 25%, contributing to death in 5% (10). At therapeutically equivalent doses, suggestions of differences in nephrotoxicity or neurotoxicity between polymyxin B and colistin are not convincing.